Skip to Content

ap RIV1.5 (Rivastigmine Tartrate 1.5 mg)

Pill with imprint ap RIV1.5 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Ajanta Pharma Limited.

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ap RIV1.5

Rivastigmine Tartrate

Imprint
ap RIV1.5
Strength
1.5 mg
Color
Yellow
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ajanta Pharma Limited
National Drug Code (NDC)
27241-0090
Inactive Ingredients
microcrystalline cellulose, hypromelloses, silicon dioxide, magnesium stearate, gelatin, titanium dioxide, ferric oxide yellow, shellac, propylene glycol, ferrosoferric oxide, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.